In this regard, gain-of-function mutations of Sos1/2 have been reported in RASopathies, particularly in patients with Noonan syndrome, who may develop skin abnormalities as well as granular skin tumors [7]. The gene discussed is SOS1; the disease is Noonan syndrome.